Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 11 sty 2021 · Results: We identified 267 514 ischemic stroke cases that were eligible for MT treatment across 32 European countries. MT was found to be more effective and cheaper than standard care in two-thirds of the countries (21/32) and cost-effective in all but one country (Bulgaria).

  2. 10 lut 2021 · The studies were categorized into one of the 4 key themes: (1) composition of stroke thrombi; (2) thrombus composition and mechanical thrombectomy; (3) thrombus composition and thrombolytic therapy; and (4) novel imaging and endovascular approaches.

  3. MT may not decrease severe bleeding risk compared to CDT except in patients with complete contraindications to thrombolytics. Providers should explore other factors such as device cost and ease of operation when deciding on therapy.

  4. 14 kwi 2023 · To compare thrombus removal and residual venous symptoms and signs of disease following interventional treatment of iliofemoral deep vein thrombosis (DVT) with mechanical thrombectomy (MT) and pharmacomechanical catheter directed thrombolysis (PCDT).

  5. 14 cze 2024 · Our study reviews MT in AIS within the context of cardiac diseases, aiming to identify existing and emerging needs and gaps. PubMed and Scopus were searched until December 31, 2023, using a combination of cardiological diseases and “mechanical thrombectomy” or “endovascular treatment” as keywords.

  6. Thrombi retrieved from patients with acute ischemic stroke are highly heterogeneous. Recent data suggest that thrombus composition may impact on mechanical thrombectomy, the number of recanalization manoeuvres, resistance to retrieval, and on thrombolytic potential.

  7. 1 kwi 2021 · Using the AngioVac system, 70%–100% thrombus or mass removal was achieved in 73.6% of patients with CTEs, 58.5% of patients with RHMs, 60% of patients with CRTs, and 57.1% of patients with PEs. Extracorporeal bypass time was < 1 hour for 176 (75.2%) procedures.

  1. Ludzie szukają również